Celecoxib API Market Size, Share & Trends Analysis Report, By Type (Standard Grade Celecoxib API, & Micronized Celecoxib API), By Application (Pharmaceutical, & Laboratory), By Region, Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Celecoxib API Market Snapshot Chapter 4. Global Celecoxib API Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis 5.1. by Type & Market Share, 2019 & 2031 5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type: 5.2.1. Standard grade Celecoxib API 5.2.2. Micronized Celecoxib API Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis 6.1. by Application & Market Share, 2019 & 2031 6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application: 6.2.1. Pharmaceutical 6.2.2. Laboratory Chapter 7. Celecoxib API Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031 7.1.2. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031 7.1.3. North America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.2. Europe 7.2.1. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031 7.2.2. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031 7.2.3. Europe Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.3. Asia Pacific 7.3.1. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031 7.3.2. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031 7.3.3. Asia Pacific Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.4. Latin America 7.4.1. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031 7.4.2. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031 7.4.3. Latin America Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 7.5. Middle East & Africa 7.5.1. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031 7.5.2. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031 7.5.3. Middle East & Africa Celecoxib API Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031 Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Pfizer (U.S.) 8.2.2. Teva Pharmaceuticals (Israel) 8.2.3. Viatris (U.S.) 8.2.4. ScinoPharm (China) 8.2.5. Jiangxi Synergy (China) 8.2.6. Jiangsu Hengrui Medicine (China) 8.2.7. Jiangsu Chiatai Qingjiang (China) 8.2.8. Hisun Pharmaceutical Nantong (China) 8.2.9. Aurobindo Pharma (India) 8.2.10. Punjab Chemicals (India) 8.2.11. Other Prominent Players